Phase II trials
Clinical Trials Watch
This section contains information about clinical trials that are:
- Currently recruiting participants
- Conducted at least in one European country
- In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)
How many Phase II trials are reported in the CTW?
The CTW reports currently 8 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:
| Study | Study sponsor | Name of the drug | Condition |
| Abvac40 | Araclon Biotech S.L. | ABvac40 | Amnestic mild cognitive impairment or very mild Alzheimer's disease |
| ACI-24-1801 | AC Immune | ACI-24 | Mild Alzheimer's disease |
| DESPIAD | University College London | CPHPC | Mild Alzheimer's disease |
| ETHERAL | Oryzon | ORY-2001 | Mild-moderate Alzheimer's disease |
| LAURIET | Genentech | RO7105705 | Moderate Alzheimer's disease |
| LM11A-31-BHS | PharmatrophiX Inc. | LM11A-31-BHS | Mild-moderate Alzheimer's disease |
| MAPT-CS1 | Ionis Pharmaceuticals, Inc. | IONIS MAPTRx | Mild Alzheimer's disease |
| VALZ-PILOT | Hugo Lovheim | Valaciclovir | Early Alzheimer's disease |
Last Updated: Friday 23 August 2019
